Freenome raises $254M for early cancer detection tests

Freenome has raised an additional $254 million in private funding, led by Roche, as the company nears pivotal results for its blood-based cancer test.

Riley Ennis

San Francisco-based Freenome is among the liquid biopsy companies that seek to pick up on cancer before patients show…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks